Shaw Christi's Insider Trades & SAST Disclosures

Shaw Christi's most recent trade in Kyverna Therapeutics Inc. was a trade of 38,679 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 14, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kyverna Therapeutics Inc.
Christi Shaw Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 38,679 38,679 - - Stock Option (right to buy)
Kyverna Therapeutics Inc.
Christi Shaw Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2024 66,592 66,592 - - Stock Option (right to buy)
Beam Therapeutics Inc
Christi Shaw Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 23,114 23,114 - - Stock Option (Right to Buy)
Beam Therapeutics Inc
Shaw Christi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 39,046 39,046 - - Stock Option (Right to Buy)
Avantor Inc.
Christi Shaw Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2023 9,808 36,271 (0%) 0% 0 Common Stock
Avantor Inc.
Christi Shaw Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2022 6,693 26,463 (0%) 0% 0 Common Stock
Avantor Inc.
Christi Shaw Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2022 1,215 19,770 (0%) 0% 0 Common Stock
Avantor Inc.
Christi Shaw Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2021 7,236 18,555 (0%) 0% 0 Common Stock
Avantor Inc.
Christi Shaw Director Sale of securities on an exchange or to another person at price $ 26.68 per share. 11 Dec 2020 14,286 11,319 (0%) 0% 26.7 381,150 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades